Cargando…

Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease

INTRODUCTION: In this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. MATERIALS AND METHODS: Liver function tests, body...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekatas, Demet D, Bahcecioglu, Ibrahim H, Ispiroglu, Murat, Sahin, Abdurrahman, Ilhan, Necip, Yalniz, Mehmet, Demirel, Ulvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578582/
https://www.ncbi.nlm.nih.gov/pubmed/29201746
http://dx.doi.org/10.5005/jp-journals-10018-1186
_version_ 1783260561641832448
author Tekatas, Demet D
Bahcecioglu, Ibrahim H
Ispiroglu, Murat
Sahin, Abdurrahman
Ilhan, Necip
Yalniz, Mehmet
Demirel, Ulvi
author_facet Tekatas, Demet D
Bahcecioglu, Ibrahim H
Ispiroglu, Murat
Sahin, Abdurrahman
Ilhan, Necip
Yalniz, Mehmet
Demirel, Ulvi
author_sort Tekatas, Demet D
collection PubMed
description INTRODUCTION: In this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. MATERIALS AND METHODS: Liver function tests, body mass index, waist circumference, lipid parameters, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), homeostasis model assessment-IR (HOMA-IR), ACE, and ACE gene polymorphism were evaluated in the NAFLD group and control group. The study group was evaluated by dividing the group into four subgroups by ACE gene polymorphism (D/D homozygous, I/I homozygous, D/I heterozygous, I/D heterozygous). Liver biopsies were evaluated according to Brunt Classification. RESULTS: A total of 31 patients who were diagnosed with NAFLD and 40 healthy individuals were included in the study. The ACE level was found to be 11.69 ± 1.99 in the NAFLD group and 11.52 ± 1.72 in the control group (p = 0.70). There was a negative correlation between ACE levels and HOMA-IR levels (p = 0.008, r= −0.512). Biochemical parameters were not different among ACE gene polimorphism subgroups, except FBG (between D/D, I/D and D/I, I/D; p = 0.02). When the ACE levels were compared in terms of grade and stage, no significant difference was found (for stage and grade p = 0.68). The ACE gene polymorphism subgroups did not differ by histopathologic findings; grade and stage (for grade p = 0.42, for stage p = 0.92). CONCLUSION: In this study, we could not find a correlation of ACE and ACE gene polymorphism with metabolic risk factors and the disease severity in NAFLD. HOW TO CITE THIS ARTICLE: Tekatas DD, Bahcecioglu IH, Ispiroglu M, Sahin A, Ilhan N, Yalniz M, Demirel U. Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2016;6(2):137-142.
format Online
Article
Text
id pubmed-5578582
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-55785822017-11-30 Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease Tekatas, Demet D Bahcecioglu, Ibrahim H Ispiroglu, Murat Sahin, Abdurrahman Ilhan, Necip Yalniz, Mehmet Demirel, Ulvi Euroasian J Hepatogastroenterol Research Article INTRODUCTION: In this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. MATERIALS AND METHODS: Liver function tests, body mass index, waist circumference, lipid parameters, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), homeostasis model assessment-IR (HOMA-IR), ACE, and ACE gene polymorphism were evaluated in the NAFLD group and control group. The study group was evaluated by dividing the group into four subgroups by ACE gene polymorphism (D/D homozygous, I/I homozygous, D/I heterozygous, I/D heterozygous). Liver biopsies were evaluated according to Brunt Classification. RESULTS: A total of 31 patients who were diagnosed with NAFLD and 40 healthy individuals were included in the study. The ACE level was found to be 11.69 ± 1.99 in the NAFLD group and 11.52 ± 1.72 in the control group (p = 0.70). There was a negative correlation between ACE levels and HOMA-IR levels (p = 0.008, r= −0.512). Biochemical parameters were not different among ACE gene polimorphism subgroups, except FBG (between D/D, I/D and D/I, I/D; p = 0.02). When the ACE levels were compared in terms of grade and stage, no significant difference was found (for stage and grade p = 0.68). The ACE gene polymorphism subgroups did not differ by histopathologic findings; grade and stage (for grade p = 0.42, for stage p = 0.92). CONCLUSION: In this study, we could not find a correlation of ACE and ACE gene polymorphism with metabolic risk factors and the disease severity in NAFLD. HOW TO CITE THIS ARTICLE: Tekatas DD, Bahcecioglu IH, Ispiroglu M, Sahin A, Ilhan N, Yalniz M, Demirel U. Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2016;6(2):137-142. Jaypee Brothers Medical Publishers 2016 2016-12-01 /pmc/articles/PMC5578582/ /pubmed/29201746 http://dx.doi.org/10.5005/jp-journals-10018-1186 Text en Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Research Article
Tekatas, Demet D
Bahcecioglu, Ibrahim H
Ispiroglu, Murat
Sahin, Abdurrahman
Ilhan, Necip
Yalniz, Mehmet
Demirel, Ulvi
Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
title Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
title_full Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
title_fullStr Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
title_full_unstemmed Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
title_short Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
title_sort role of renin–angiotensin-converting enzyme level and ace gene polymorphism in patients with nonalcoholic fatty liver disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578582/
https://www.ncbi.nlm.nih.gov/pubmed/29201746
http://dx.doi.org/10.5005/jp-journals-10018-1186
work_keys_str_mv AT tekatasdemetd roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease
AT bahceciogluibrahimh roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease
AT ispiroglumurat roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease
AT sahinabdurrahman roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease
AT ilhannecip roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease
AT yalnizmehmet roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease
AT demirelulvi roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease